Keywords: 5-HT1A; serotonin 1A receptor; AE; adverse events; AIDS; acquired immunodeficiency syndrome; CB1; cannabinoid-one receptor; CB2; cannabinoid-two receptor; CBD; cannabidiol; CBDA; cannabidiolic acid; CRISP-R; Clustered Regularly Interspaced Short Palindrom
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: cannabinoid; CB2; chronic kidney disease; inverse agonist; renal fibrosis;
Keywords: Cannabinoids; Phytocannabinoids; Endocannabinoids; Therapeutic agents; AEA; Arachidonylethanolamine or Anandamide; 2-AG; 2-arachidonylglycerol; CB1; Cannabinoid receptor type 1; CB2; Cannabinoid receptor type 2; CBD; Cannabidiol; CBG; Cannabigerol; CBL; C
Keywords: AEA; anandamide; BS; behavioral sensitization; CB1; cannabinoid receptor type 1; CB2; cannabinoid receptor type 2; CL; conditioned locomotion; Coc; cocaine; CPP; conditioned place preference; CS+; positive conditioned stimulus; CS-; neutral conditioned st
Keywords: 2-AG; arachidonoylglycerol; AI; alkylindole; CB; cannabinoid; CB1; cannabinoid receptor 1; CB2; cannabinoid receptor 2; CSA4; combretastatin A4; DBT; delayed Brain Tumor; HA; hemagglutinin; LPA; lysophosphatidic acid; GBM; glioblastoma multiforme; SAR; st
Keywords: Antinociception; CB2 cannabinoid receptor agonist; Inflammation; Morphine; Reward; Synergy; 2-AG; 2-arachidonoylglycerol; %MPE; percent maximal possible effect; A50; potency; a-CSF; artificial spinal fluid; CB1; cannabinoid 1 receptor; CB2; cannabinoid 2
Keywords: Cnr2; CB2; Osteolysis; Cancer; Bone; Osteoclast; Osteoblast; Osteoporosis;
Keywords: 2-AG; 2-arachidonoyglycerol; AEA; arachidonoylethanolamide; AEs; acylethanolamides; CB1; cannabinoid receptor 1; CB2; cannabinoid receptor 2; DAGL; diacylglycerol lipase; eCBs; endocannabinoids; ECS; endogenous cannabinoid system; FAAH; fatty acid amide h
Keywords: 5-HIAA; 5-hydroxyindole-3-acetic acid; AMPA; aminohydroxymethyl isoxazole propionate receptor; ANOVA; analysis of variance; BLA; basolateral nucleus of the amygdala; CA; Ammon's horn of the hippocampus; CB1; cannabinoid subtype 1 receptor; CB2; cannabin
Keywords: Homeostasis; Obesity; Pharmacotherapy; Reward; AgRP; agouti-related protein; α-MSH; alpha-melanocyte stimulating hormone; 2-AG; 2-arachidonoylglycerol; BDNF; brain derived neurotrophic factor; BOLD; blood-oxygen level dependent; CB1; cannabinoid-1; CB2;
Keywords: ADF; acid detergent fibre expressed inclusive residual ash; ADIN; acid detergent insoluble nitrogen; CA; rapidly degradable sugars; CB1; intermediately degradable starch and pectins; CB2; slowly degradable plant cell wall; CC; unavailable/lignin-bound cel
Keywords: 2-AG; 2-arachidonoylglycerol; ALK; anaplastic lymphoma kinase; ATF-4; activating transcription factor 4; CB1; cannabinoid CB1 receptor; CB2; cannabinoid CB2 receptor; CBD; cannabidiol; CHOP; C/EBP homologous protein; EGFR; epidermal growth factor receptor
Keywords: hA1AR; human adenosine A1 receptor; hA2AAR; A2AR, human adenosine A2A receptor; hA2BAR; human adenosine A2B receptor; hA3AR; human adenosine A3 receptor; ADORA2A; adenosine A2A receptor gene; AR; adenosine receptor; cAMP; cyclic adenosine 5â²-monophospha
Keywords: 2-AG; 2-arachidonoylglycerol; AA; arachidonic acid; ABHD4; α/β-hydrolase domain-containing protein 4; ABHD6; α/β-hydrolase domain-containing protein 6; ABHD12; α/β-hydrolase domain-containing protein 12; AEA; arachidonoylethanolamine; CB1; cannabino
Keywords: 2-AG; 2-arachidonoyl-glycerol; AEA; anandamide; CB1; cannabinoid receptor type 1; CB2; cannabinoid receptor type 2; CNS; central nervous system; DOPAC; 3,4-Dihydroxyphenylacetic acid; DA; dopamine; D2; dopamine receptor subtype 2; ECS; endocannabinoid sys
Keywords: AEF; atrioesophageal fistula; AF; atrial fibrillation; AT; atrial tachycardia; CB; cryoballoon; CB1; first-generation cryoballoon; CB2; second-generation cryoballoon; CI; confidence interval; EFI; early freezing interruption; LET; luminal esophageal tempe
Keywords: Alzheimer's disease; CB2; CCL2; Endocannabinoid system; Microglia; Neuroinflammation;
Keywords: Akt; protein kinase B; CB1; cannabinoid type-1 receptor; CB2; cannabinoid type-2 receptor; D2; dopamine type-2 receptor; Î9-THC; Î9-tetrahydrocannabinol; EEG; electroencephalography; ERK; extracellular signal-regulated kinase; FAAH; fatty acid amide hyd
Keywords: AEA; anandamide; ANOVA; analysis of variance; ARRIVE; Animal Research: Reporting of In Vivo Experiments guidelines; BDNF; brain-derived neurotrophic factor; BK; Big Potassium channels; CBr; cannabinoid receptors; CBs; cannabinoids; CB1; type-1 cannabinoid
Keywords: 2-AG; 2-arachidonylglycerol; 2-OG; 2-oxogluteric acid; AEA; N-arachidonoylethanolamide; CB1; cannabinoid type 1 receptor; CB1â/â/CB2â/â; CB1 and CB2 deficient; CB2; cannabinoid type 2 receptor; CK; cytokeratin; DAGLα; diacylglycerol lipase α; DA
Keywords: Abn-CBD; abnormal cannabidiol,4-[(1R,6R)-3-methyl-6(1-methyletheÂnyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol; ACEA; N-(2-Chloroethyl)-5Z,8Z,11Z,14Z-eicÂosatetraenamide; AM251; N-(Piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-p
Keywords: Cathinone; JWH; CB1; CB2; DAT; SERT; NET; Releaser; 5HT; TAAR1
Keywords: Amphetamine; Endocannabinoids; Glutamate; Monoamines; Endogenous opioids; Pharmacology; 5-HT; serotonin; ACh; acetylcholine; ADHD; attention-deficit/hyperactivity disorder; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; BDNF; brain-derived n
Keywords: ADF; acid detergent fibre; ADICP; acid detergent insoluble crude protein; ADIN; acid detergent insoluble nitrogen; ADL; acid detergent lignin; AECP; truly absorbable endogenous protein; AMCP; truly absorbable microbial protein synthesized in the rumen; AR
Keywords: 2-AG; 2-arachidonylglycerol; 5-HT; 5-hydroxytryptamine; ACC; anterior cingulate cortex; AEA; anandamide; AMPA; alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; CB1; cannabinoid receptor 1; CB2; cannabinoid type 2; CCK; cholecystokinin; CCK2; chol
Keywords: 2-AG; 2-arachidonoylglycerol; AA; arachidonic acid; ABA; activity-based anorexia; ACC1; acetyl coenzyme-A carboxylase-1; AEA; N-arachidonoylethanolamine; AN; anorexia nervosa; ARC; arcuate nucleus; BBB; blood-brain barrier; BED; binge eating disorder; BN;
Keywords: AMT; α-methyl-l-tryptophan; BBB; blood-brain barrier; CB1; cannabinoid receptor type 1; CB2; cannabinoid receptor type 2; CNS; central nervous system; FLAIR; fluid-attenuated inversion recovery; Gd-DTPA; gadolinium-diethylenetriaminepentacetate; GFAP;
Keywords: CB1; CB2; Endocannabinoid system; Fatty liver disease; Fibrosis; Steatosis; Liver regeneration; Kupffer cells; Inflammation.;
Keywords: Maternal deprivation; Endocannabinoids; Morphine consumption; Selective CB1 antagonist/inverse agonist; SR141716A; Rat; AEA; N-arachidonoylethanolamine; AFR; animal facility rearing; AM404; inhibitor of endocannabinoid membrane transporter; CB1; cannabino
Keywords: 5-HT; 5-Hydroxytryptamine or serotonin; AA-5-HT; N-arachidonoyl-serotonin; ACEA; arachidonoyl 2â²-chloroethylamide; AEA; N-arachidonoylethanolamine; 2-AG; 2-arachidonoylglycerol; AM251; N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-
Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants
Keywords: CYP450; CYP2C9 variants; Synthetic cannabinoids; Enzyme kinetics; Toxicity; Î9-THC; (â)-Î9-Tetrahydrocannabinol; P450; cytochrome P450; CYP; specific P450; UGTs; uridine diphosphate (UDP)-glucuronosyltransferases; LC-MS/MS; Liquid chromatography-tande
Oximes short-acting CB1 receptor agonists
Keywords: CB1; CB2; cannabinoid receptors; GPCR; Î9-THC; (-)-Î9-Tetrahydrocannabinol; Î8-THC; Î8-THC-DMH; Arachidonoylethanolamine (AEA); 2-Arachidonoylglycerol (2-AG); Analgesia; Anorexia Nervosa (AN);
Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection
Keywords: SC; synthetic cannabinoid; CB1; central cannabinoid receptors; CB2; peripheral cannabinoid receptors; HRMS; high resolution mass spectrometry; FullMS; full-scan mass spectrometry; ddMS2; data-dependent tandem mass spectrometry; AGC; automatic gain control
Redox system and phospholipid metabolism in the kidney of hypertensive rats after FAAH inhibitor URB597 administration
Keywords: 2-AG; 2-arachidonoylglycerol; 4-HNE; 4-hydroxynonenal; 8-isoPGF2α; F2 -isoprostanes; 8-OHdG; 8-hydroxy-2'-deoxyguanosine; AA; arachidonic acid; AEA; N-arachidonoylethanolamine, anandamide; AM3506; 5-(4-hydroxyphenyl) pentanesulfonyl fluoride; Bach1; ba
FAAH inhibition attenuates TLR3-mediated hyperthermia, nociceptive- and anxiety-like behaviour in female rats
Keywords: AEA; anandamide; ADT; acetone drop test; CB1; cannabinoid receptor 1; CB2; cannabinoid receptor 2; CD11b; cluster of differentiation molecule; 11b; CD68, cluster of differentiation 68; CNS; central nervous system; COX-2; cyclooxygenase 2; EPM; elevated pl
Synthesis and pharmacological characterization of functionalized 6-piperazin-1-yl-purines as cannabinoid receptor 1 (CB1) inverse agonists
Keywords: BBB; Blood-Brain Barrier; CB1; Cannabinoid Receptor 1; CB2; Cannabinoid Receptor 2; CHO-K1; Chinese Hamster Ovary Cells; CNS; Central Nervous System; EtOH; ethanol; EtOAc; ethyl acetate; Ke; apparent affinity constant, MDCK-mdr1, Madin-Darby canine kidney
Bortezomib and endocannabinoid/endovanilloid system: a synergism in osteosarcoma
Keywords: Endocannabinoid/Endovanilloid system; Osteosarcoma; Bortezomib; CB2; TRPV1;
Antinociceptive effects of the endogenous cannabinoid peptide agonist VD-hemopressin(β) in mice
Keywords: ANOVA; analysis of variance; AM251; N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3- carboxamide; AM630; 6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3- yl(4-methoxyphenyl)-methanone; AUC; area under the curve; CB1
Mast cell degranulation and calcium influx are inhibited by an Echinacea purpurea extract and the alkylamide dodeca-2E,4E-dienoic acid isobutylamide
Keywords: A15; alkylamide 15; Ã-hex; beta-hexosaminidase; BMMC; bone marrow-derived mast cell; CRAC; calcium-release activated calcium; CB2; cannabinoid receptor type 2; ER; endoplasmic reticulum; FcεRI; fragment crystallizable epsilon receptor 1; IACUC; Institut
Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation
Keywords: JZL184; Rat; Monoacylglycerol lipase (MAGL); Inhibitory avoidance; Fear memory; Behavior; JZL184 [4-[Bis(1,3-benzodioxol-5-yl)hydroxymethyl]-1-piperidinecarboxylic acid 4-nitrophenyl ester]; MAGL inhibitor; SR141716 [5-(4-chlorophenyl)-1-(2,4-dichlorophen
CB1 cannabinoid receptor agonist mouse VD-hemopressin(α) produced supraspinal analgesic activity in the preclinical models of pain
Keywords: AM251; N-(piperidin-1-yl-5-(4-iodophenyl-1-(2,4-dichlorophenyl-4-methyl-1H-pyrazole-3-carboxamide; AM4113; 5-(4-alkylphenyl-1-(2,4-dichlorophenyl-4-methyl-N-(piperidin-1-yl-1H-pyrazole-3-carboxamide; AM630; 6-iodo-2-methyl-1-[2-(4-morpholinylethyl]-1H-ind
Age-related regulation of bone formation by the sympathetic cannabinoid CB1 receptor
Keywords: eCBs; endocannabinoids; AEA; arachidonoyl ethanolamide; 2-AG; 2-arachidonoylglycerol; CB1; cannabinoid-1; CB2; cannabinoid-2; β2AR; β2 adrenergic receptors; NE; norepinephrine; CNS; central nervous system; DBH; dopamine-β-hydroxylase; BV/TV; bone volum
Experimental ischemia/reperfusion model impairs endocannabinoid signaling and Na+/K+ ATPase expression and activity in kidney proximal tubule cells
Keywords: 2-AG; 2-arachidonoylglycerol; AEA; anandamide; AM251; N-(piperidin-1-yl)-1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxamide; CB1; cannabinoid type-1 receptor; CB2; cannabinoid type-2 receptor; DGL; diacylglycerol lipase; ECS; endoc
Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice
Keywords: 2-AG; 2-arachidonoylglycerol; CB1; Cannabinoid receptor subtype 1; CB2; Cannabinoid receptor subtype 2; FAAH; Fatty acid amide hydrolase; JZL184; 4-nitrophenyl-4-[bis(1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate; JWH-018; Naphthalen-1-yl-
Pharmacological characterization of rat VD-hemopressin(α), an α-hemoglobin-derived peptide exhibiting cannabinoid agonist-like effects in mice
Keywords: ANOVA; analysis of variance; AUC; area under the curve; CB1; cannabinoid receptor type 1; CB2; cannabinoid receptor type 2; CP55,940; (2)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol; dNPA; D.NP(N-Me)AFLFQPQRFamide;
β-Caryophyllene ameliorates the development of experimental autoimmune encephalomyelitis in C57BL/6 mice
Keywords: MS; multiple sclerosis; EAE; experimental autoimmune encephalomyelitis; BCP; β-caryophyllene; CNS; central nervous system; MOG35-55; myelin oligodendrocyte glycoprotein peptide; NO; nitrite oxide; H2O2; hydrogen peroxide; IFN-γ; interferon gamma; TNF-α
Chronic CB1 cannabinoid receptor antagonism persistently increases dendritic spine densities in brain regions important to zebra finch vocal learning and production in an antidepressant-sensitive manner
Keywords: CB1; cannabinoid receptor 1; CB2; cannabinoid receptor 2; SR; SR141716A; MAOI; monoamine oxidase inhibitor; HVC; used as a proper name; Area X; Area X of striatum; DLM; nucleus dorsolateralis anterior, pars medialis; IMAN; lateral magnocellular nucleus of
Research paperCannabidiol (CBD) induces functional Tregs in response to low-level T cell activation
Keywords: BCS; bovine calf serum; BFA; Brefeldin A; CBD; cannabidiol; CB1; cannabinoid receptor 1; CB2; cannabinoid receptor 2; cpm; counts per minute; DW; deionized water; ELISA; enzyme linked immunosorbent assay; FOXP3; forkhead box P3; FVD; fixable viability dye
Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice
Keywords: Neuropathic pain; Paclitaxel; Cannabinoid; β-caryophyllene; BCP; β-caryophyllene; CB2; Cannabinoid type-2 receptor; CIPN; Chemotherapy-induced peripheral neuropathy; CNS; Central Nervous System; MCP-1; Monocyte Chemoattractant Protein 1; PINP; Paclitaxe
Anxious behavior induces elevated hippocampal Cb2 receptor gene expression
Keywords: 2-AG; 2-arachidonoylglycerol; CeA; central amygdala; DG; dentate gyrus; NPS; neuropeptide S; SAM; Stress-Alternatives Model; anxiety; Cb2; endocannabinoid; exercise; induction; hippocampus;